Current best evidence on prescribed drugs

Drugdocs Logo

Current best evidence on prescribed drugs

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Giapreza

Chemical Nameangiotensin II
Dosage FormInjection (intravenous; 2.5 mg/mL)
Drug ClassHormones
SystemCardiovascular
CompanyLa Jolla Pharma
Approval Year2017

Indication

  • Indicated to increase blood pressure in adults with septic or other distributive shock.
Last updated on 9/9/2022

More on this drug: Clinical Trials

Document TitleYearSource
Giapreza (angiotensin II) Prescribing Information.2020La Jolla Pharmaceutical Company, San Diego, CA
Document TitleYearSource
Assessment report: Giapreza.2019EMA
Angiotensin II: a new vasopressor for the treatment of distributive shock.2019Clinical Therapeutics
Document TitleYearSource
Novel vasopressors in the treatment of vasodilatory shock: a systematic review of angiotensin II, selepressin, and terlipressin.2018Journal of Intensive Care Medicine

Have we missed a study, or would you like to comment on a study?